Linda Duska, MD, FASCO, MPH, discusses the importance of the KEYNOTE-A18 study reinforcing the new standard of care of pembrolizumab plus concurrent chemoradiotherapy in locally advanced cervical ...

Malware with corrupted DOS and PE headers evades detection for weeks, decrypts TLS-based C2 and enables full attacker control ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Late-Breaking Data Presented at ASCO 2025 and Simultaneously Published in The New England Journal of Medicine THOUSAND OAKS, Calif., June 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced ...

and CSP-style concurrent programming features. Google’s Go compiler, “gc”, aims various platforms including Linux, OS X, Windows and Unix, and smartphones (from 2015). A second compiler ...

AI OS can transform both internal operations and the services delivered to clients, though it is not without its challenges.

Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase–Targeted Approaches PD-1 immune checkpoint blockade administered subsequent to rather than concurrent with chemoradiotherapy ...